LH Aug 2022 320.000 call
| Previous close | 26.60 |
| Open | 26.60 |
| Bid | 10.80 |
| Ask | 13.50 |
| Strike | 320.00 |
| Expiry date | 2022-08-19 |
| Day's range | 26.60 - 26.60 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
- Business Wire
Tigerlily Foundation and Labcorp Collaborate to Increase Clinical Trial Diversity for Women of Color
BURLINGTON, N.C. & ALDIE, Va., June 24, 2022--Labcorp, a leading global life sciences company, and Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, today announced a new collaboration to increase clinical trial diversity for women of color and co-create health equity solutions. Labcorp has signed Tigerlily’s #InclusionPledge for Black Women, joining other healthcare and life sciences companies in committing to eradicate barriers for women of color in acces
- Zacks
LabCorp (LH) Partners HealthVerity to Grow in Drug Development
According to LabCorp (LH), this partnership is expected to broaden its comprehensive, end-to-end drug development and clinical trial programs.
- Zacks
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
Investors are optimistic about LabCorp's (LH) robust Drug Development business performance and several pandemic-related developments.
